Description

TheCultrex®3DSpheroidColorimetricProliferation/ViABIlityAssayutilizesa3DCultureQualified96WellSpheroidFormationPlatealongsideaspecializedSpheroidFormationECMtodriveaggregationand/orspheroidformationofcells.Uponcompletionofspheroidformation,thespheroidmaybetreatedwithpharmacologicalagentstoevaluatetumorviabilityafterdrugtreatment.Tumorspheroidexpansionisvisualizedmicroscopicallyandcanbequantifiedthroughimageanalysissoftwareforreal-timeandlabelfreeevaluation.Attheconclusionoftheassay,cellviabilitymaybeassessedbyabsorbanceusingMTT.The3DSpheroidColorimetricProliferation/ViabilityAssayoffersaninvitro,standardized,three-dimensional,highcontentformatforinducingmulticellulartumorspheroid(MCTS)formationandquantitifyingcellviabilitywithinthespheroidsinresponsetopharmacologicaltreatment.

 

Catalog#3511-096-Kincludes:
CatalogNumber	Description	Qty
3500-096-01	Cultrex®SpheroidFormationMatrix	1
3500-096-02	3DCultureQualified96WellSpheroidFormationPlatewithStripSeals	1
3511-096-01	MTTReagent	1
3511-096-02	DetergentReagent	1

Trevigen公司位于美国马里兰州的高科技走廊，是一家有12年历史、成长迅速的生物技术公司，其产品和技术的发展方向主要在癌症研究领域，重点强调细胞凋亡、DNA损伤和修复，以及癌症细胞功能和行为。Trevigen品牌的分销商遍及北美，欧洲和环太平洋地区。关于DNA的损伤分析技术的研究，Trevigen获得美国国立卫生研究院（NIH）的SBIR项目资助。